Junjun Li

Dr. Junjun Li

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2015 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
KKKen-ichiro Kamei
Ken-ichiro Kamei
YMYasumasa Mashimo
Yasumasa Mashimo
YKYoshie Koyama
Yoshie Koyama
CFChristopher Fockenberg
Christopher Fockenberg
MNMiyuki Nakashima
Miyuki Nakashima
YCYong Chen
Yong Chen

1 November 2017 in Stem Cell Reports
Verified
Journal Article
Open access
JLJunjun Li
Junjun Li
IMItsunari Minami
Itsunari Minami
MSMotoko Shiozaki
Motoko Shiozaki
LYLeqian Yu
Leqian Yu
SYShin Yajima
Shin Yajima
LLLi Liu
Li Liu
High-purity cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are promising for drug development and myocardial regeneration. However, most hiPSC-derived CMs morphologically and functionally resemble immature rather than adult CMs, which could hamper their application. Here, we obtained high-quality cardiac tissue-like constructs (CTLCs) by cultivating hiPSC-CMs on low-thickness aligned nanofibers made of biodegradable poly(D,L-lactic-co-glycolic acid) polymer. We show that multilayered and elongated CMs could be organized at high density along aligned nanofibers in a simple one-step seeding process, resulting in upregulated cardiac biomarkers and enhanced cardiac functions. When used for drug assessment, CTLCs were much more robust than the 2D conventional control. We also demonstrated the potential of CTLCs for modeling engraftments in vitro and treating myocardial infarction in vivo. Thus, we established a handy framework for cardiac tissue engineering, which holds high potential for pharmaceutical and clinical applications.

30 June 2016 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YTYadong Tang
Yadong Tang
LLLi Liu
Li Liu
JLJunjun Li
Junjun Li
LYLeqian Yu
Leqian Yu
LWLi Wang
Li Wang
YCYong Chen
Yong Chen
Extensive efforts have been devoted to develop new substrates for culture and differentiation of human induced pluripotent stem cells (hiPSCs) toward cardiac cell-based assays. A more exciting prospect is the construction of cardiac tissue for robust drug screening and cardiac tissue repairing. Here, we developed a patch method by electrospinning and crosslinking of monolayer gelatin nanofibers on a honeycomb frame made of poly(ethylene glycol) diacrylate (PEGDA). The monolayer of the nanofibrous structure can support cells with minimal exogenous contact and a maximal efficiency of cell–medium exchange whereas a single hiPSC colony can be uniformly formed in each of the honeycomb compartments. By modulating the treatment time of the ROCK inhibitor Y-27632, the shape of the hiPSC colony could be controlled from a flat layer to a hemisphere. Afterwards, the induction and differentiation of hiPSCs were achieved on the same patch, leading to a uniform cardiac layer with homogeneous contraction. This cardiac layer could then be used for extracellular recording with a commercial multi-electrode array, showing representative field potential waveforms of matured cardiac tissues with appropriate drug responses.

Verified
Journal Article
Open access
PDF file
JLJunjun Li
Junjun Li
YHYING HUA
YING HUA
SMShigeru Miyagawa
Shigeru Miyagawa
JZJingbo Zhang
Jingbo Zhang
LLLingjun Li
Lingjun Li
ASAnd Yoshiki Sawa
And Yoshiki Sawa
Relevant, predictive normal, or disease model systems are of vital importance for drug development. The difference between nonhuman models and humans could contribute to clinical trial failures despite ideal nonhuman results. As a potential substitute for animal models, human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) provide a powerful tool for drug toxicity screening, modeling cardiovascular diseases, and drug discovery. Here, we review recent hiPSC-CM disease models and discuss the features of hiPSC-CMs, including subtype and maturation and the tissue engineering technologies for drug assessment. Updates from the international multisite collaborators/administrations for development of novel drug discovery paradigms are also summarized.

13 March 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
JLJunjun Li
Junjun Li
LZLu Zhang
Lu Zhang
LYLeqian Yu
Leqian Yu
IMItsunari Minami
Itsunari Minami
SMShigeru Miyagawa
Shigeru Miyagawa
LLLi Liu
Li Liu
Directed differentiation methods allow acquisition of high-purity cardiomyocytes differentiated from human induced pluripotent stem cells (hiPSCs); however, their immaturity characteristic limits their application for drug screening and regenerative therapy. The rapid electrical pacing of cardiomyocytes has been used for efficiently promoting the maturation of cardiomyocytes, here we describe a simple device in modified culture plate on which hiPSC-derived cardiomyocytes can form three-dimensional self-organized tissue rings (SOTRs). Using calcium imaging, we show that within the ring, reentrant waves (ReWs) of action potential spontaneously originated and ran robustly at a frequency up to 4 Hz. After 2 weeks, SOTRs with ReWs show higher maturation including structural organization, increased cardiac-specific gene expression, enhanced Ca2+-handling properties, an increased oxygen-consumption rate, and enhanced contractile force. We subsequently use a mathematical model to interpret the origination, propagation, and long-term behavior of the ReWs within the SOTRs.

1 April 2017 in Biomaterials
Verified
Journal Article
Closed access
LLLi Liu
Li Liu
KKKen-ichiro Kamei
Ken-ichiro Kamei
MYMomoko Yoshioka
Momoko Yoshioka
MNMinako Nakajima
Minako Nakajima
JLJunjun Li
Junjun Li
YCYong Chen
Yong Chen